The findings reveal the major contributors, hotspot evolution, and developmental trends in this field, thereby providing readers with a reference for understanding the research landscape and future directions of laser-based wound treatment.
True laser LLLT was associated with improved healing and excellent safety; however, it rests on three small trials with a lower confidence bound approaching no effect, warranting caution.
Adjunctive formulations were associated with additional short-term improvements in clinician-rated scar outcomes and an exploratory optical measure, without a demonstrated additional patient-reported benefit.
The proposed framework provides a practical approach for deriving representative optical coefficients from heterogeneous literature data and highlights the importance of standardized, multilayered tissue models for accurate and reproducible light-dosimetry simulations.
Both sequential DPL-CO2 laser therapy and CO2 laser monotherapy were associated with favorable clinical trajectories in early postoperative linear scars over 6 months.
PDRN enhanced fibroblast proliferation and TGFB1 expression, whereas PBM favored COL3A1 and ELN expression. Further studies should optimize treatment parameters and investigate the therapeutic potential of combining PBM and PDRN for skin rejuvenation.
Photobiomodulation may be an effective treatment for pressure ulcers in frail older adults, substantially accelerating healing, and reducing recurrence, with potential to lessen patient burden and improve outcomes.
The therapeutic effects of PBM appear to be dose-dependent and influenced by treatment parameters including wavelength, fluence, irradiance, and exposure protocol.
The treatment duration of PPV can be shortened and the phototherapy platform stage can be avoided. Conversely, the combination treatment did not yield satisfactory results for vitiligo in the acral region.
Fractional CO₂ laser combined with intradermal and topical PRP provided greater improvement in clinical scar scores than laser alone, with an acceptable safety profile.
No severe adverse events occurred. Preliminary evidence suggests that NAFL-assisted delivery of biomimetic growth factors is a safe and effective non-invasive treatment for AGA.
PBM remained associated with a higher exploratory tissue repair score after adjustment for healing day, diabetes status, and contemporaneous VEGF, whereas VEGF itself was not independently associated with repair.
HA spray yielded significantly accelerated re-epithelialization and superior early pain reduction compared to LLLT following gingivectomy, suggesting it may serve as a practical, patient-friendly adjunctive alternative to laser biostimulation in postoperative wound management.
At-home LED photobiomodulation devices appear to be safe and effective for improving facial aging parameters, particularly those emitting red and near-infrared wavelengths.
These findings support the potential of low-intensity infrared laser irradiation as a minimally invasive adjunct to scaffold-assisted tympanic membrane repair.
Patient satisfaction scores were comparable, and no serious adverse events occurred. Overall, the fractionated 1064-nm picosecond Nd: YAG laser produced short-term postoperative scar outcomes statistically equivalent to those observed with PDL, with good tolerability.
No device-related adverse events occurred at hybrid-mode sites. The synchronized hybrid 755-nm/1064-nm mode produced superior hair-thickness reduction compared with single 755-nm treatment, with comparable satisfaction and favourable tolerability.
These cases suggest that PDL may offer a novel therapeutic option for CRD-associated dysesthesias, particularly when integrated with multidisciplinary care involving medical dermatology, laser specialists, and wound care.
The combination of Clinical LLLT and the proprietary hair growth serum appears effective and well-tolerated for AGA treatment. While early results are encouraging, larger, controlled studies are necessary to validate findings and assess long-term efficacy.
These hypothesis-generating associations require prospective confirmation and do not establish a causal treatment effect. The sample size and retrospective recording limit conclusions about safety.
Skin thermal damage represents a "physical dissolution" process characterized by cumulative internal structural disruption, necessitating protection strategies fundamentally different from UV blocking.
The 1064-nm Nd: YAG picosecond laser is a well-tolerated treatment option for Becker's nevus, demonstrating moderate efficacy. A significant moderate positive correlation was observed between the number of treatments and clinical outcome in Becker's nevus without hypertrichosis.
High fluences of 405 nm blue light photobiomodulation was generally well tolerated in this small cohort and was considered safe for use in patients with chronic wounds.
Available comparative evidence suggests a favorable clinical-response signal for fractional CO₂ laser, accompanied by greater procedural pain and longer recovery.